DGAP-News: StemCells, Inc. Announces World–s First Neural Stem Cell Transplant in Spinal Cord Injury Patient
StemCells, Inc.
22.09.2011 15:00
—————————————————————————
NEWARK, Calif., 2011-09-22 15:00 CEST (GLOBE NEWSWIRE) —
StemCells, Inc. (Nasdaq:STEM) announced today that the first patient in the
Company–s breakthrough Phase I/II clinical trial in chronic spinal cord injury
was successfully transplanted with the Company–s proprietary HuCNS-SC(r) adult
neural stem cells. The stem cells were administered yesterday at Balgrist
University Hospital,
